Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Predictmedix Inc.
  6. News
  7. Summary
    PMED   CA74040L1004

PREDICTMEDIX INC.

(PMED)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Predictmedix Inc. Files Registration Statement on Form 20-F With the SEC

06/18/2021 | 08:05am EST

TORONTO, June 18, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), announced today that it has filed a registration statement on Form 20-F to register its common shares with the United States Securities and Exchange Commission (the “SEC”). Once the registration statement has been declared effective by the SEC, the Company will be a reporting issuer under the United States securities laws.

About Predictmedix Inc.

Predictmedix (CSE: PMED | OTCQB: PMEDF) is an AI (Artificial Intelligence) company developing disruptive technologies for the health and safety of people at work, in public environments, and by supporting healthcare systems with AI powered tools to facilitate better care and outcomes. Our AI powered screening products analyze real-time data from multispectral cameras and other sensors to detect when individuals may exhibiting symptoms of COVID-19 & other infectious diseases and also impairment due to alcohol & cannabis. We are also expanding our technology to screen for mental illnesses such as Alzheimer's, dementia, and depression. To learn more about our partnerships, where to buy our solutions, and company updates, visit Predictmedix.com.

Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."

Predictmedix Inc. trades as “PMED” on the Canadian Securities Exchange and “PMEDF” on the OTCQB market in the United States.

For more information, visit predictmedix.com
Or follow us on our social media platforms:
Twitter
Instagram
LinkedIn
Information that may be important to investors will be routinely posted on all these sites.

Investor Relations:

Ehsan Agahi, Investor Relations
Tel: (778) 229-4319
Email: IR@predictmedix.com

Caution Regarding Forward-Looking Information:

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law. 


Primary Logo


ę GlobeNewswire 2021
All news about PREDICTMEDIX INC.
11/02Predictmedix Safe Entry Station Receives CE Mark Approval and ISO Certification for Com..
PU
10/26Predictmedix Deploys Safe Entry Stations At Formula 1 Aramco United States Grand Prix
CI
10/25Predictmedix Deployed Safe Entry Stations at Formula 1 Aramco United States Grand Prix
PU
10/15Predictmedix Inc. Secures New Strategic Partnership with Entertainment Bay, India LLP
CI
10/15Predictmedix Inc. Announces Strategic Partnership with Paras TechCare
CI
10/12Predictmedix Launches Next-Generation Corporate Website
PU
10/05Predictmedix Secures Strategic Partnership with Entertainment Bay India LLP, a Tier-1 I..
PU
10/04Predictmedix to Present at LD Micro Main Event on October 12, 2021
PU
09/29Predictmedix Inc. Reports Earnings Results for the Second Quarter Ended July 31, 2021
CI
09/15PREDICTMEDIX : to Present at Benzinga Healthcare Small Cap Conference
AQ
More news
Financials
Sales 2021 - - -
Net income 2021 -1,58 M -1,23 M -1,23 M
Net cash 2021 0,48 M 0,37 M 0,37 M
P/E ratio 2021 -17,0x
Yield 2021 -
Capitalization 22,8 M 17,8 M 17,8 M
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees -
Free-Float 73,2%
Chart PREDICTMEDIX INC.
Duration : Period :
Predictmedix Inc. Technical Analysis Chart | PMED | CA74040L1004 | MarketScreener
Income Statement Evolution
Managers and Directors
Sheldon Kales President, Chief Executive Officer & Director
Rakesh Malhotra Chief Financial Officer & Secretary
Rahul Kushwah Chief Operating Officer & Director
Ajit Kumar Independent Director
Tomas Sipos Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PREDICTMEDIX INC.-35.38%18
SMC CORPORATION17.74%43 157
COGNEX CORPORATION-5.36%13 433
SHIMADZU CORPORATION20.70%12 341
MKS INSTRUMENTS, INC.3.14%8 606
WUHAN GUIDE INFRARED CO., LTD.-16.37%8 501